Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 5.06
-0.04 (-0.78%)
Sep 4, 2026, 4:00 PM EST
Medexus Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Medexus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $7.25. The average 1-year stock price forecast is 43.28% higher than the current stock price, while the lowest is $6.00 (+18.58%) and the highest is $9.00 (+77.87%).
Price Target: $7.25 (+43.28%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medexus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bloom Burton | Bloom Burton | Buy Maintains $6.00 → $6.50 | Buy | Maintains | $6.00 → $6.50 | +28.46% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
114.97M
from 99.33M
Increased by 15.74%
Revenue Next Year
138.47M
from 114.97M
Increased by 20.44%
EPS This Year
0.38
EPS Next Year
0.66
from 0.38
Increased by 73.57%
EPS and Forward PE are based on non-GAAP adjusted numbers.